Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine (Q26801198)

DAA treatment

1 reference

PubMed ID

26251895

author

Hauke Sebastian Heinzow

4

Hauke S Heinzow

0 references

Iyad Kabar

2

Iyad Kabar

0 references

Hartmut H-J Schmidt

3

Hartmut H Schmidt

0 references

Anna Hüsing-Kabar

1

International Journal of Molecular Sciences

Anna Hüsing

0 references

language of work or name

English

0 references

publication date

5 August 2015

13 references

13 March 2019

14 March 2019

23 March 2019

21 March 2019

22 June 2019

3 November 2019

29 May 2020

1 July 2020

27 October 2020

15 July 2021

22 October 2022

25 October 2022

26 October 2022

13 references

13 March 2019

14 March 2019

23 March 2019

21 March 2019

22 June 2019

3 November 2019

29 May 2020

1 July 2020

27 October 2020

15 July 2021

22 October 2022

25 October 2022

26 October 2022

16

0 references

page(s)

18033-53

0 references

issue

8

0 references

copyright license

Creative Commons Attribution

13 references

13 March 2019

14 March 2019

23 March 2019

21 March 2019

22 June 2019

3 November 2019

29 May 2020

1 July 2020

27 October 2020

15 July 2021

22 October 2022

25 October 2022

26 October 2022

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant Patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

The evidence-based epidemiology of HCV-associated kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Viral hepatitis in liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Effect of kidney transplantation on outcomes among patients with hepatitis C

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Trends in waiting list registration for liver transplantation for viral hepatitis in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Hepatitis C infection and chronic renal diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Hepatitis C and renal transplantation: a review on historical aspects and current issues

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Hepatitis C virus infection in haemodialysis and kidney transplant patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Hepatitis C virus infection in dialysis and renal transplantation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Impact of hepatitis B and C virus on kidney transplantation outcome

31 May 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Outcome of HCV infection after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Liver transplantation in the United States, 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818033

KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581234

Clinical outcome of HCV infection after renal transplantation

28 November 2018

1 reference

12 December 2020

Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts

1 reference

12 December 2020

A SPECIAL MEETING REVIEW EDITION: Highlights in the Treatment of Hepatitis C Virus From the 2014 Liver Meeting: A Review of Selected Presentations From the 2014 Liver Meeting November 7-11, 2014 • Boston, MassachusettsSpecial Reporting on:• Evaluati

1 reference

12 December 2020

A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver • April 22-26, 2015 • Vienna, AustriaSpecial Reporting on:• Dac

1 reference

12 December 2020